Profile data is unavailable for this security.
About the company
Beijing Succeeder Technology Inc is a China-based company mainly engaged in the research and development, production and sales of testing instruments, reagents and consumables in the field of thrombosis and hemostasis in vitro diagnosis. The Company provides medical institutions with automated detection equipment for blood coagulation, blood rheology, hematocrit, platelet aggregation, and supporting reagents and consumables. Its products include testing instruments, reagents and consumables, such as automatic coagulation testers, coagulation quality control kits, Newtonian fluid quality controls, reaction cups and SAW blood rheology special cleaning. The Company operates its businesses within the domestic market and to overseas markets.
- Revenue in CNY (TTM)284.54m
- Net income in CNY120.76m
- Incorporated2003
- Employees296.00
- LocationBeijing Succeeder Technology IncTower 1A, No.27 Innovation RoadScience and Technology Park, Changping DBEIJING 102200ChinaCHN
- Phone+86 1 053855568
- Fax+86 1 053855570
- Websitehttp://www.succeeder.com.cn
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jiangsu Cowin Biotech Co Ltd | 123.20m | -117.37m | 2.21bn | 657.00 | -- | 1.36 | -- | 17.97 | -1.12 | -1.12 | 1.21 | 14.49 | 0.0664 | 1.33 | 1.23 | 187,520.90 | -6.63 | -- | -6.94 | -- | 58.15 | -- | -99.82 | -- | 14.37 | -- | 0.0184 | -- | -67.15 | -- | -153.00 | -- | -- | -- |
Ginwa Enterprise Group Inc | 572.93m | -23.61m | 2.32bn | 553.00 | -- | 1.44 | -- | 4.05 | -0.0633 | -0.0633 | 1.53 | 4.32 | 0.2988 | 4.74 | 5.64 | 1,036,046.00 | -1.23 | 0.3641 | -1.44 | 0.4141 | 75.60 | 73.64 | -4.12 | 1.15 | 3.33 | 0.3439 | 0.0206 | 124.25 | -2.41 | -5.37 | -228.19 | -- | 61.66 | -- |
Beijing Succeeder Technology Inc | 284.54m | 120.76m | 2.37bn | 296.00 | 19.63 | 1.45 | -- | 8.33 | 1.14 | 1.14 | 2.68 | 15.36 | 0.1711 | 2.39 | 9.52 | 961,290.60 | 7.26 | 7.77 | 7.63 | 8.25 | 62.48 | 61.03 | 42.43 | 38.34 | 14.58 | -- | 0.00007 | 22.22 | 20.40 | 6.60 | 12.29 | 15.57 | 99.03 | -- |
Novoprotein Scientific Inc | 136.28m | -927.60k | 2.41bn | 579.00 | -- | 1.10 | -- | 17.66 | -0.0132 | -0.0132 | 1.94 | 31.19 | 0.0585 | 0.4493 | 1.67 | 235,364.30 | -0.0398 | -- | -0.0409 | -- | 70.17 | -- | -0.6807 | -- | 34.49 | -- | 0.0353 | -- | -42.09 | -- | -85.84 | -- | -- | -- |
Cabio Biotech Wuhan Co Ltd | 473.06m | 101.38m | 2.41bn | 508.00 | 23.94 | 1.60 | -- | 5.09 | 0.5977 | 0.5977 | 2.79 | 8.92 | 0.2948 | 2.49 | 2.27 | 931,222.90 | 6.01 | 7.81 | 6.55 | 8.34 | 41.34 | 46.96 | 20.40 | 28.65 | 6.19 | -- | 0.008 | 39.86 | 2.39 | 9.18 | 41.95 | -1.19 | 89.01 | -- |
GuiZhou YiBai Pharmaceutical Co., Ltd. | 2.71bn | -9.06m | 2.48bn | 5.51k | -- | 0.8265 | -- | 0.9149 | -0.0114 | -0.0114 | 3.42 | 3.79 | 0.56 | 1.47 | 11.26 | 491,815.10 | -0.4457 | 0.8618 | -0.6067 | 1.17 | 66.49 | 74.87 | -0.7958 | 1.45 | 1.32 | 1.67 | 0.2392 | 216.36 | 3.12 | -6.19 | 124.25 | -- | -16.51 | -- |
Ningbo Menovo Pharmaceutical Co Ltd | 1.23bn | -17.82m | 2.49bn | 2.35k | -- | 1.17 | -- | 2.02 | -0.0997 | -0.0997 | 5.23 | 9.99 | 0.2811 | 1.31 | 6.18 | 523,989.50 | -0.3253 | 4.94 | -0.4782 | 7.83 | 30.72 | 35.39 | -1.16 | 13.71 | 0.7935 | 0.7647 | 0.4042 | 10.78 | -16.51 | 7.46 | -96.58 | -34.53 | -6.03 | -32.54 |
Henan Taloph Pharmaceutical Stock Co Ltd | 2.01bn | 61.13m | 2.52bn | 2.35k | 42.89 | 1.54 | -- | 1.25 | 0.1024 | 0.1024 | 3.51 | 2.84 | 0.556 | 3.30 | 2.13 | 853,677.20 | 1.72 | 0.272 | 3.55 | 0.4981 | 26.76 | 27.97 | 3.09 | 0.5501 | 0.9283 | 2.02 | 0.3637 | 28.70 | 5.57 | 11.62 | 160.32 | -- | -8.27 | -- |
Holder | Shares | % Held |
---|---|---|
China Southern Asset Management Co., Ltd.as of 31 Dec 2023 | 1.44m | 2.26% |
E Fund Management Co., Ltd.as of 31 Dec 2023 | 1.33m | 2.10% |
Zhong Geng Fund Management Co. , Ltd.as of 31 Dec 2023 | 928.47k | 1.46% |
Gfund Management Co., Ltd.as of 31 Dec 2023 | 379.90k | 0.60% |
Penghua Fund Management Co., Ltd.as of 31 Dec 2023 | 263.84k | 0.41% |
GF Fund Management Co., Ltd.as of 31 Dec 2023 | 233.28k | 0.37% |
Huatai-PineBridge Fund Management Co., Ltd.as of 30 Jun 2023 | 226.49k | 0.36% |
Zheshang Fund Management Co., Ltd.as of 30 Jun 2023 | 196.47k | 0.31% |
Maxwealth Fund Management Co., Ltd.as of 31 Dec 2023 | 176.50k | 0.28% |
Golden Trust Sinopac Fund Management Co., Ltd.as of 31 Dec 2023 | 75.00k | 0.12% |